Trial intelligence / Profile preview

Propofol versus insulin for myocardial protection in on-pump valvular cardiac surgery

PACTR201710002696183Unknown

Sponsor
Minia University
Start
Mar 2015
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Trial of propofol and human insulin in Cardiac valve disease (VHD) (2 arms), sponsored by Minia University. Primary endpoint: Myocardial protection assessed by left papillary biopsy and troponin I. Status: unknown.

02

Drugs

propofolhuman insulin
03

Conditions

Cardiac valve disease (VHD)

Beyond the preview

Go deeper on PACTR201710002696183.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201710002696183.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call